Prescience Point says MiMedx worth ‘at least $8.09,’ announces long position

Prescience Point announced that it is long MiMedx, which it called “one of the most undervalued companies we have ever identified.” Prescience Point estimates the stock is “worth at least $8.09, almost 4x the current price.” The firm stated in its newly published report: “As frequent publishers of short-biased research, we believe short-selling is vital to the markets and agree with critics that MiMedx has engaged in wrongdoing. But we disagree on the extent of that wrongdoing, and believe that the company will overcome its current challenges and eventually thrive again.”
https://thefly.com/landingPageNews.php?id=2845529